Buagafuran study in people with and without liver problems
Part of Mental health clinical trials.
This trial tests how the body processes the study drug Buagafuran in people with mild to moderate liver impairment compared to those with healthy livers. It aims to understand dosing and safety for patients with liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have either stable mild to moderate liver impairment (Child-Pugh A or B) or a healthy liver.
- Your kidney function is normal (creatinine clearance at least 60 mL/min).
- Your weight is at least 50 kg for men or 45 kg for women, with a BMI between 18 and 32.
- You have no severe allergies, heart rhythm problems, or recent major surgeries.
- You are willing to avoid pregnancy and follow contraceptive rules for 6 months after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called buagafuran for people with generalized anxiety disorder (GAD). It aims to see if the drug can safely reduce anxiety symptoms.
This trial tests a new capsule called Buagafuran for adults with generalized anxiety disorder (GAD). It aims to see if the medication helps reduce anxiety without causing major side effects.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
This trial studies how a new drug, buagafuran, interacts with voriconazole (an antifungal medication). Healthy volunteers take both drugs to see if one affects the levels of the other in the body. The goal is to make sure the combination is safe and to understand dosing.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.